We are live on ! Find out more
VCA

Verdence Capital Advisors Portfolio holdings

AUM $1.9B
1-Year Est. Return 36.41%
This Fund
S&P 500
This Quarter Est. Return
+12.84%
1 Year Est. Return
+36.41%
3 Year Est. Return
+97.11%
5 Year Est. Return
+121.09%
10 Year Est. Return
AUM
$369M
AUM Growth
+$12.1M
Cap. Flow
-$26.3M
Cap. Flow %
-7.12%
Top 10 Hldgs %
21.25%
Holding
282
New
44
Increased
129
Reduced
79
Closed
13

Top Buys

Rank Stock Value
1
SCZ icon
iShares MSCI EAFE Small-Cap ETF
SCZ
+$5.09M
2
MRSH
Marsh
MRSH
+$2.83M
3
WSFS icon
WSFS Financial
WSFS
+$2.82M
4
GS icon
Goldman Sachs
GS
+$2.46M
5
AAPL icon
Apple
AAPL
+$2.12M

Sector Composition

Rank Sector Weight
1 Financials 22.2%
2 Technology 14.42%
3 Healthcare 10.17%
4 Industrials 9.75%
5 Energy 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOV icon
201
Dover
DOV
$27.6B
$310K 0.08%
+3,309
New +$286K
UAL icon
202
United Airlines
UAL
$39.4B
$308K 0.08%
3,855
-114
-3% -$9.62K
CSX icon
203
CSX Corp
CSX
$93.4B
$298K 0.08%
+11,937
New +$276K
LOW icon
204
Lowe's Companies
LOW
$117B
$298K 0.08%
2,721
-1,360
-33% -$136K
IWF icon
205
iShares Russell 1000 Growth ETF
IWF
$121B
$294K 0.08%
+7,760
New +$279K
EXC icon
206
Exelon
EXC
$47.2B
$293K 0.08%
8,183
+26
+0.3% +$885
ECL icon
207
Ecolab
ECL
$78.1B
$290K 0.08%
+1,644
New +$267K
GE icon
208
GE Aerospace
GE
$374B
$288K 0.08%
5,787
-25
-0.4% -$1.18K
VCEL icon
209
Vericel Corp
VCEL
$2.35B
$287K 0.08%
16,388
TMO icon
210
Thermo Fisher Scientific
TMO
$213B
$286K 0.08%
+1,046
New +$260K
SYF icon
211
Synchrony
SYF
$24.7B
$281K 0.08%
+8,800
New +$265K
CL icon
212
Colgate-Palmolive
CL
$73.1B
$279K 0.08%
4,068
+675
+20% +$43.6K
DAL icon
213
Delta Air Lines
DAL
$57.5B
$278K 0.08%
5,380
+550
+11% +$27.3K
CDK
214
DELISTED
CDK Global, Inc.
CDK
$277K 0.08%
4,705
+51
+1% +$2.78K
EQNR icon
215
Equinor
EQNR
$97.7B
$272K 0.07%
12,362
+570
+5% +$12.8K
WM icon
216
Waste Management
WM
$90.6B
$271K 0.07%
+2,604
New +$254K
CVS icon
217
CVS Health
CVS
$133B
$265K 0.07%
4,905
+617
+14% +$38.1K
VPL icon
218
Vanguard FTSE Pacific ETF
VPL
$8.08B
$264K 0.07%
+4,010
New +$260K
VTI icon
219
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$261K 0.07%
1,805
-1,995
-53% -$278K
CELG
220
DELISTED
Celgene Corp
CELG
$258K 0.07%
2,731
-557
-17% -$48.7K
MVV icon
221
ProShares Ultra MidCap400
MVV
$153M
$256K 0.07%
+6,561
New +$244K
BLK icon
222
Blackrock
BLK
$169B
$254K 0.07%
595
+39
+7% +$16.4K
VOE icon
223
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$252K 0.07%
2,334
-515
-18% -$54.1K
BAX icon
224
Baxter International
BAX
$13.5B
$248K 0.07%
+3,056
New +$222K
HUBB icon
225
Hubbell
HUBB
$25B
$247K 0.07%
+2,094
New +$237K

Similar funds

Verdence Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Verdence Capital Advisors held 282 positions worth $369M, up 3.4% from $357M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Verdence Capital Advisors withdrew a net $26.3M in Q1 2019, closing 13 positions and reducing 79 holdings. Its most notable exit was Beneficial Bancorp, Inc., an estimated $3.21M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Verdence Capital Advisors opened a new position in Marsh worth $3M.

  • Verdence Capital Advisors's largest Q1 2019 buy was Marsh: 31,957 shares worth $3M.
  • Verdence Capital Advisors added most to iShares MSCI EAFE Small-Cap ETF in Q1 2019, an estimated $5.09M increase.
  • Verdence Capital Advisors's biggest Q1 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $11.2M.
  • Verdence Capital Advisors fully exited Beneficial Bancorp, Inc. in Q1 2019, selling an estimated $3.21M.
  • Verdence Capital Advisors's ten largest holdings make up 21% of its $369M portfolio in Q1 2019.
  • Verdence Capital Advisors opened 44 new positions and closed 13 in Q1 2019.
  • Verdence Capital Advisors's portfolio value rose 3.4% quarter-over-quarter to $369M.

Based on Verdence Capital Advisors's 13F filing for Q1 2019, filed 2 Mar 2020.